A typographical error was published in the review ‘Which antidepressants have demonstrated superior efficacy? A review of the evidence’ by (Montgomery et al. ) which appeared in 323–329 of International Clinical Psychopharmacology, Volume 22, issue 6.
The following declaration of research grants, equity and/or honoraria for lectures or for acting as consultants to pharmaceutical companies should have appeared in the conflict of interest statement in the acknowledgement section of the article.
Alan F. Schatzberg – Abbott, Corcept, Eli Lilly, Forest Labs, GlaxoSmithKline, Lundbeck, Merck, Neurocrine, Neuronetics, Novartis, Pathway Diagnostics, Pfizer, Quintiles, Somaxon, Somerset, Wyeth; named inventor on pharmacogenetic use patents on prediction of antidepressant response.
International Clinical Psychopharmacology.